Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Tissue Antigens

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1399-0039.2006.00672.XPMID 17026470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-myelin antibodies in multiple sclerosis: clinically useful?

  2006cited by this paper
• The Journal of Experimental Medicine CORRESPONDENCE

  2005cited by this paper
• Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

  2005cited by this paper
• Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.

  2005cited by this paper
• Immunology of multiple sclerosis.

  2005cited by this paper
• IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

  2005cited by this paper
• Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

  2005cited by this paper
• A PD‐1 polymorphism is associated with disease progression in multiple sclerosis

  2005cited by this paper
• Association of CD40 Gene Polymorphism (C-1T) with Susceptibility and Phenotype of Graves' Disease

  2005cited by this paper
• A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology.

  2005cited by this paper
• Differential responses of human B‐lymphocyte subpopulations to graded levels of CD40–CD154 interaction

  2005cited by this paper
• Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

  2005cited by this paper
• Plasma exchange for severe optic neuritis

  2004cited by this paper
• Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis

  2004cited by this paper
• A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

  2004cited by this paper
• The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.

  2004cited by this paper
• CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells1

  2003cited by this paper
• Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

  2003cited by this paper
• Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies

  2003cited by this paper
• A C/T Single-Nucleotide Polymorphism in the Region of the CD40 Gene is Associated with Graves' Disease

  2002cited by this paper
• CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis.

  2002cited by this paper
• Signaling by CD40 and its mimics in B cell activation

  2001cited by this paper
• Association between clinical disease activity and Epstein–Barr virus reactivation in MS

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro.

  1996cited by this paper
• CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

  1996cited by this paper
• Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

  1995cited by this paper
• The CD40 antigen and its ligand.

  1994cited by this paper
• Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

  1993cited by this paper

• Primary Progressive Multiple Sclerosis: New Therapeutic Approaches

  2025cites this paper
• Meta-analysis of the Selected Genetic Variants in Immune-Related Genes and Multiple Sclerosis Risk

  2024cites this paper
• Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice

  2023cites this paper
• "Genetic variability of molecules involved in the disease pathogenesis in Leishmania infection".

  2020cites this paper
• Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis

  2017cites this paper
• Increased ex vivo antigen presentation profile of B cells in multiple sclerosis

  2017cites this paper
• Impact of population admixture on the distribution of immune response co-stimulatory genes polymorphisms in a Brazilian population.

  2015cites this paper
• The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function

  2015cites this paper
• Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients.

  2014cites this paper
• Investigation of gene-gene interactions between CD40 and CD40L in Polish multiple sclerosis patients.

  2014cites this paper
• CD40 and tolerance induction.

  2012cites this paper
• CD40 C/T-1 polymorphism plays different roles in Graves' disease and Hashimoto's thyroiditis: a meta-analysis.

  2012cites this paper
• Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers

  2012cites this paper
• [Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression].

  2012cites this paper
• Therapeutic Approaches to Multiple Sclerosis

  2010cites this paper
• Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.

  2010cites this paper
• CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility

  2010cites this paper
• Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis

  2010cites this paper
• Manifestations of Biopsy-proven Giant Cell Arteritis rs 1883832 Polymorphism in Susceptibility to and Clinical CD 40 Influence of 1

  2010cites this paper
• Clinical associations of the genetic variants of CTLA‐4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease

  2010cites this paper
• CD40 and autoimmunity: the dark side of a great activator.

  2009cites this paper
• STAT2*C related genotypes and allele but not TLR4 and CD40 gene polymorphisms are associated with higher susceptibility for asthma

  2009cites this paper
• Individual and epistatic effects of genetic polymorphisms of B-cell co-stimulatory molecules on susceptibility to pemphigus foliaceus

  2009cites this paper
• Chapter 6 The Genetics of Autoimmune Thyroid Diseases

  2008cites this paper
• A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression

  2007cites this paper
• The Genetic Basis of Thyroid Autoimmunity

  2007cites this paper
• The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

  2007cites this paper